Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2015

01-08-2015 | Breast Oncology

Characteristics of Multifocal and Multicentric Breast Cancers

Authors: Prathima Kanumuri, MD, Brandon Hayse, BSc, Brigid K. Killelea, MD, MPH, Anees B. Chagpar, MD, MSc, MPH, MA, Nina R. Horowitz, MD, Donald R. Lannin, MD

Published in: Annals of Surgical Oncology | Issue 8/2015

Login to get access

Abstract

Background

Multifocality and multicentricity are increasingly recognized in breast cancer. However, little is known about the characteristics and biology of these cancers and the clinical implications are controversial.

Methods

A retrospective, institutional database was used to compare characteristics of multifocal (MF) and multicentric (MC) breast cancers with unifocal (UF) cancers to study concordance of histology and receptor status among primary and secondary foci and to evaluate predictors of lymph node positivity using multivariate logistic regression.

Results

Of 1495 invasive cancers, 1231 (82.3 %) were UF, 169 (11.3 %) were MF, and 95 (6.4 %) were MC cancers. When MF and MC cancers were compared with UF cancers, MC but not MF cancers were associated with young age at diagnosis, larger tumor size, lymphovascular invasion, and node positivity. MF but not MC tumors were more likely to be ER/PR+Her2+ tumors and less likely to be triple-negative cancers compared with UF tumors. MF tumors were more likely to be infiltrating ductal carcinomas with an extensive intraductal component, and MC tumors were more likely to be infiltrating lobular carcinomas. Concordance of histology and receptor status between primary and secondary foci was high and was similar for both MF and MC cancers. Multicentricity remained an independent predictor of lymph node positivity on multivariate analysis.

Conclusion

MF and MC tumors seem to be biologically different diseases. MC is clinicopathologically more aggressive than MF disease and is more frequently associated with younger age and larger tumor size and also is an independent predictor of node positivity.
Literature
1.
go back to reference Cheatle G. Benign and malignant changes in duct epithelium of the breast. Br J Cancer. 1920;8(31):285–306. Cheatle G. Benign and malignant changes in duct epithelium of the breast. Br J Cancer. 1920;8(31):285–306.
2.
3.
go back to reference Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–58.PubMedCrossRef Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–58.PubMedCrossRef
4.
go back to reference Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149–57.PubMedCrossRef Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149–57.PubMedCrossRef
5.
go back to reference Girardi V, Carbognin G, Camera L, et al. Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer. Radiol Med. 2011;116(8):1226–38.PubMedCrossRef Girardi V, Carbognin G, Camera L, et al. Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer. Radiol Med. 2011;116(8):1226–38.PubMedCrossRef
6.
go back to reference Jain S, Rezo A, Shadbolt B, Dahlstrom JE. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology. 2009;41(1):57–67.PubMedCrossRef Jain S, Rezo A, Shadbolt B, Dahlstrom JE. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology. 2009;41(1):57–67.PubMedCrossRef
7.
go back to reference Bendifallah S, Werkoff G, Borie-Moutafoff C, et al. Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol. 2010;19(4):e115–23.PubMedCrossRef Bendifallah S, Werkoff G, Borie-Moutafoff C, et al. Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol. 2010;19(4):e115–23.PubMedCrossRef
8.
go back to reference Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol. 2012;23(4):876–81.PubMedCrossRef Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol. 2012;23(4):876–81.PubMedCrossRef
9.
go back to reference Ustaalioglu BO, Bilici A, Kefeli U, et al. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience. Am J Clin Oncol. 2012;35(6):580–6.PubMedCrossRef Ustaalioglu BO, Bilici A, Kefeli U, et al. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience. Am J Clin Oncol. 2012;35(6):580–6.PubMedCrossRef
10.
go back to reference Weissenbacher TM, Zschage M, Janni W, et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat. 2010;122(1):27–34.PubMedCrossRef Weissenbacher TM, Zschage M, Janni W, et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat. 2010;122(1):27–34.PubMedCrossRef
11.
go back to reference Oh JL, Dryden MJ, Woodward WA, et al. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006;24(31):4971–5.PubMedCrossRef Oh JL, Dryden MJ, Woodward WA, et al. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006;24(31):4971–5.PubMedCrossRef
12.
go back to reference Wolters R, Wockel A, Janni W, et al. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat. 2013;142(3):579–90.PubMedCrossRef Wolters R, Wockel A, Janni W, et al. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat. 2013;142(3):579–90.PubMedCrossRef
13.
14.
go back to reference Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50(3):735–42.PubMedCrossRef Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50(3):735–42.PubMedCrossRef
15.
go back to reference Rezo A, Dahlstrom J, Shadbolt B, et al. Tumor size and survival in multicentric and multifocal breast cancer. Breast. 2011;20(3):259–63.PubMedCrossRef Rezo A, Dahlstrom J, Shadbolt B, et al. Tumor size and survival in multicentric and multifocal breast cancer. Breast. 2011;20(3):259–63.PubMedCrossRef
16.
go back to reference Cabioglu N, Ozmen V, Kaya H, et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009;208(1):67–74.PubMedCrossRef Cabioglu N, Ozmen V, Kaya H, et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009;208(1):67–74.PubMedCrossRef
17.
go back to reference Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg. 2001;71(12):723–8.PubMedCrossRef Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg. 2001;71(12):723–8.PubMedCrossRef
18.
go back to reference Edge S. AJCC cancer staging manual. New York: Springer; 2010. Edge S. AJCC cancer staging manual. New York: Springer; 2010.
19.
go back to reference Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94(5):1383–90.PubMedCrossRef Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94(5):1383–90.PubMedCrossRef
20.
go back to reference Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol. 2005;23(30):7497–502.PubMedCrossRef Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol. 2005;23(30):7497–502.PubMedCrossRef
21.
go back to reference Boyages J, Jayasinghe UW, Coombs N. Multifocal breast cancer and survival: each focus does matter particularly for larger tumours. Eur J Cancer. 2010;46(11):1990–6.PubMedCrossRef Boyages J, Jayasinghe UW, Coombs N. Multifocal breast cancer and survival: each focus does matter particularly for larger tumours. Eur J Cancer. 2010;46(11):1990–6.PubMedCrossRef
22.
go back to reference O’Daly BJ, Sweeney KJ, Ridgway PF, et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J Am Coll Surg. 2007;204(2):282–5.PubMedCrossRef O’Daly BJ, Sweeney KJ, Ridgway PF, et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J Am Coll Surg. 2007;204(2):282–5.PubMedCrossRef
23.
go back to reference Hilton JF, Bouganim N, Dong B, et al. Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials. Breast Cancer Res Treat. 2013;142(1):143–51.PubMedCrossRef Hilton JF, Bouganim N, Dong B, et al. Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials. Breast Cancer Res Treat. 2013;142(1):143–51.PubMedCrossRef
24.
go back to reference Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol. 1995;26(9):965–9.PubMedCrossRef Dawson PJ, Baekey PA, Clark RA. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol. 1995;26(9):965–9.PubMedCrossRef
25.
go back to reference Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer. 2004;91(4):775–82.PubMedCentralPubMed Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer. 2004;91(4):775–82.PubMedCentralPubMed
26.
go back to reference Eeles R, Knee G, Jhavar S, et al. Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat. 2011;129(3):703–16.PubMedCrossRef Eeles R, Knee G, Jhavar S, et al. Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat. 2011;129(3):703–16.PubMedCrossRef
27.
go back to reference Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002;94(7):1910–6.PubMedCrossRef Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002;94(7):1910–6.PubMedCrossRef
28.
go back to reference Choi Y, Kim EJ, Seol H, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012;43(1):48–55.PubMedCrossRef Choi Y, Kim EJ, Seol H, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012;43(1):48–55.PubMedCrossRef
29.
go back to reference Buggi F, Folli S, Curcio A, et al. Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol. 2012;23(8):2042–6.PubMedCrossRef Buggi F, Folli S, Curcio A, et al. Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified? Ann Oncol. 2012;23(8):2042–6.PubMedCrossRef
30.
go back to reference Pekar G, Gere M, Tarjan M, Hellberg D, Tot T. Molecular phenotype of the foci in multifocal invasive breast carcinomas: intertumoral heterogeneity is related to shorter survival and may influence the choice of therapy. Cancer. 2014;120(1):26–34.PubMedCrossRef Pekar G, Gere M, Tarjan M, Hellberg D, Tot T. Molecular phenotype of the foci in multifocal invasive breast carcinomas: intertumoral heterogeneity is related to shorter survival and may influence the choice of therapy. Cancer. 2014;120(1):26–34.PubMedCrossRef
31.
go back to reference Boros M, Marian C, Moldovan C, Stolnicu S. Morphological heterogeneity of the simultaneous ipsilateral invasive tumor foci in breast carcinoma: a retrospective study of 418 cases of carcinomas. Pathol Res Pract. 2012;208(10):604–9.PubMedCrossRef Boros M, Marian C, Moldovan C, Stolnicu S. Morphological heterogeneity of the simultaneous ipsilateral invasive tumor foci in breast carcinoma: a retrospective study of 418 cases of carcinomas. Pathol Res Pract. 2012;208(10):604–9.PubMedCrossRef
Metadata
Title
Characteristics of Multifocal and Multicentric Breast Cancers
Authors
Prathima Kanumuri, MD
Brandon Hayse, BSc
Brigid K. Killelea, MD, MPH
Anees B. Chagpar, MD, MSc, MPH, MA
Nina R. Horowitz, MD
Donald R. Lannin, MD
Publication date
01-08-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 8/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4430-6

Other articles of this Issue 8/2015

Annals of Surgical Oncology 8/2015 Go to the issue